Florence Releases 2021 State of Clinical Trial Technology Industry Report
Florence Healthcare has released its annual State of Clinical Trial Technology Industry Report. More than 230 clinical operations professionals across the drug development lifecycle participated in this year's report, revealing how they plan to invest in technology over the next three years.
Key findings from the survey conducted online in late November and early December include:
- 47% of sites and 36% of sponsors indicated they increased their 2020 technology budgets to reduce disruptions from COVID.
- 65% of sites intend to have an electronic investigator site file (eISF) in place by the end of 2020, and 47% expect to use eConsent.
- 90% of sites state that increasing their chances of being selected by a sponsor for a study is one of their primary reasons for investing in technology.
- 80% of sites and 83% of sponsors anticipate that most or all of their monitoring visits will be conducted remotely by 2023.
For more of the report’s findings, click here.
Telemedicine Considerations When Conducting Decentralized Clinical Trials
January 14th 2025Compliance with state telemedicine requirements is imperative, as not only will most clinical trial sponsors contractually require such compliance, but non-compliance may also subject the practitioner to licensure violations and liability.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
